Cephalosporins: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
*'''1st Gen [[Cephalosporins]]''' | *'''1st Gen [[Cephalosporins]]''' | ||
** Cefazolin, [[Cephalexin]] | ** Cefazolin, [[Cephalexin]] | ||
| Line 31: | Line 29: | ||
*** Enterobacter, pseudomonas, H. influenzae, gonococci | *** Enterobacter, pseudomonas, H. influenzae, gonococci | ||
*** Little allergic cross-reactivity with B-lactam antibiotics | *** Little allergic cross-reactivity with B-lactam antibiotics | ||
{{Template:Clinically Utilized Antibiotics}} | |||
==See Also== | ==See Also== | ||
Revision as of 23:42, 10 February 2014
- 1st Gen Cephalosporins
- Cefazolin, Cephalexin
- Skin and soft tissue infections (why is agent of choice before gen sx)
- Cross-reactivity of PCN allergy <10%
- Cefazolin, Cephalexin
- 2nd Gen Cephalosporins
- Cefuroxime
- Intestinal anaerobes (why is agent of chioce for colorectal sx)
- Largely displaced by 3rd gen agents
- Cefuroxime
- 3rd Gen Cephalosporins
- Ceftriaxone, Ceftazidime, Cefixime
- Drug of choice for serious infections due to:
- Klebsiella
- Enterobacter
- Proteus
- Haemophilus
- Gonorrhea
- Lyme disease
- Meningitis (+ vanc and ampicillin)
- Pseudomonas meningitis (+ AG)
- Drug of choice for serious infections due to:
- Ceftriaxone, Ceftazidime, Cefixime
- 4th Gen Cephalosporins
- Cefepime
- Resistant, nosocomial infections
- Cefepime
- Carbapenems
- Imipenem (+ cilastatin), meropenem
- Cephalosporin-resistant nosocomial bacteria
- Empirical treatment of serious infections in patients who recently received other b-lactams
- Imipenem (+ cilastatin), meropenem
- Aztreonam
- Antimicrobial activity more closely resembles AG's (only active against gram -)
- Enterobacter, pseudomonas, H. influenzae, gonococci
- Little allergic cross-reactivity with B-lactam antibiotics
- Antimicrobial activity more closely resembles AG's (only active against gram -)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
See Also
Source
Goodman & Gilman's Pharmacology
